These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11776583)

  • 1. [Intervention treatment with percutaneous trans-arterial implantation of port-catheter system for advanced cancer patients].
    Huang J; Wu P; Zhang F
    Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):386-8. PubMed ID: 11776583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic and splenic arterial infusion chemotherapy after transcatheter peripancreatic arterial embolization for patients with inoperable adenocarcinoma of the pancreas].
    Homma H; Kukitsu T; Mezawa S; Doi T; Kida M; Miyanishi K; Takada K; Murase K; Iyama S; Niitsu Y
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1558-61. PubMed ID: 11707979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
    Han GH; Yin ZX; Meng XJ; He CY; Zhang HB; Sun AH; Wu KC; Ding J; Fan DM
    Chin J Dig Dis; 2006; 7(1):45-8. PubMed ID: 16412037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional and synthetic therapy of advanced hepatocellular carcinoma.
    Cao X; He N; Sun J; Wang S; Ji X; Fan H; Wang J; Zhang C; Yang J; Lu T; Li J; Zhang G
    Chin Med J (Engl); 2002 Dec; 115(12):1883-5. PubMed ID: 12622945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implanted percutaneous continuous hepatic arterial infusion system for nonresectable liver metastasis].
    Zhu K; Shan H; Li Z
    Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):493-6. PubMed ID: 11859719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
    Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
    Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal of port-catheter system for hepatic arterial infusion chemotherapy implanted with fixed catheter tip method.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
    J Vasc Interv Radiol; 2006 Apr; 17(4):651-6. PubMed ID: 16614148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infusion chemotherapy and chemoembolization of liver metastases from cancer of the alimentary tract].
    Zeng H; Li H; Shi Z
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):422-4. PubMed ID: 11778283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous hepatic artery infusion chemotherapy and chemoembolization for treatment of patients with liver metastases from colorectal cancer].
    Zhao Y; Wang SM; Zhang J
    Ai Zheng; 2002 Apr; 21(4):421-3. PubMed ID: 12452025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
    Iguchi T; Arai Y; Inaba Y; Yamaura H; Sato Y; Miyazaki M; Shimamoto H
    Cardiovasc Intervent Radiol; 2008; 31(1):86-90. PubMed ID: 17926088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead.
    Malagari K; Alexopoulou E; Chatzimichail K; Hall B; Koskinas J; Ryan S; Gallardo E; Kelekis A; Gouliamos A; Kelekis D
    Abdom Imaging; 2008; 33(5):512-9. PubMed ID: 17938995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver.
    Ruutiainen AT; Soulen MC; Tuite CM; Clark TW; Mondschein JI; Stavropoulos SW; Trerotola SO
    J Vasc Interv Radiol; 2007 Jul; 18(7):847-55. PubMed ID: 17609443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter redundancy in the aortic arch increases the risk of stroke in left subclavian arterial port-catheter systems.
    Hirota T; Yamagami T; Tanaka O; Iida S; Kato T; Nishimura T
    J Vasc Interv Radiol; 2005 Apr; 16(4):471-6. PubMed ID: 15802446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma by placing a temporary catheter via the subclavian route.
    Liang HL; Huang JS; Lin YH; Lai KH; Yang CF; Pan HB
    Acta Radiol; 2007 Sep; 48(7):734-40. PubMed ID: 17729003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD; Bleck JS; Dettmer A; Chavan A; Rosenthal H; Merkesdal S; Frericks B; Zender L; Malek NP; Greten TF; Kubicka S; Manns MP; Galanski M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):259-66. PubMed ID: 17548248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.